Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02070861
Other study ID # 2013/1605
Secondary ID
Status Completed
Phase N/A
First received February 23, 2014
Last updated April 14, 2018
Start date April 2014
Est. completion date June 2015

Study information

Verified date April 2018
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators hypothesize that changes in blood circulation can be reflected by exhaled CO2 provided CO2-production in the tissues and ventilation from the lungs are stable. The investigators want to explore changes in cardiac output (the amount of blood being pumped out of the heart each minute) in patients using different devices: an esophagus ultrasound device measuring cardiac output, a finger cuff measuring blood pressure and cardiac output, and exhaled carbondioxide in the patients` breath measured by the ventilator.

The investigators investigate patients after bypass surgery or heart valve replacement, and induce changes in cardiac output with passive leg raise or ventricular pacing.


Description:

Measurements with the finger cuff (pulse contour analyses) were aborted due to technical difficulties.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date June 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 95 Years
Eligibility Inclusion Criteria:

- Persons 18 years or older scheduled to undergo arteriocoranary bypass surgery or aortic valve replacement.

Exclusion Criteria:

- Esophageal pathology, EF <40%

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Ventricular pacing and passive leg raise
Ventricular pacing and passive leg raise

Locations

Country Name City State
Norway Oslo University Hospital, Ullevål Oslo

Sponsors (2)

Lead Sponsor Collaborator
Oslo University Hospital The Norwegian Air Ambulance Foundation

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in cardiac output 5 Minutes